174 related articles for article (PubMed ID: 9387324)
1. [Detection of micrometastases in axillary lymph nodes of node-negative breast cancer patients and its clinical significance].
Wu J; Yu Z; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):289-91. PubMed ID: 9387324
[TBL] [Abstract][Full Text] [Related]
2. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
4. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
5. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
6. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
Lachman MF; Ricci A; Pedersen CA; Cartun RW; Strumpf KB
Conn Med; 1992 Feb; 56(2):65-8. PubMed ID: 1373112
[TBL] [Abstract][Full Text] [Related]
7. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cytokeratin-positive breast cancer metastases.
Sedmak DD; Meineke TA; Knechtges DS; Anderson J
Mod Pathol; 1989 Sep; 2(5):516-20. PubMed ID: 2479008
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
11. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up.
Susnik B; Frkovic-Grazio S; Bracko M
Ann Surg Oncol; 2004 Jun; 11(6):568-72. PubMed ID: 15150071
[TBL] [Abstract][Full Text] [Related]
12. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
13. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
14. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
[TBL] [Abstract][Full Text] [Related]
15. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
[TBL] [Abstract][Full Text] [Related]
17. [Detection of occult tumor cells in resected lymph nodes of patients with stage I carcinoma and its clinico-pathological significance].
Chen Z; Lu X; Huang R
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):69-71. PubMed ID: 10743062
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
19. Occult axillary lymph node metastases discovered by serial section in node-negative breast cancer.
Karalak A; Homcha-Em P
J Med Assoc Thai; 1999 Oct; 82(10):1017-9. PubMed ID: 10561965
[TBL] [Abstract][Full Text] [Related]
20. [Detection of lymph nodes micrometastases in breast carcinoma using immunohistochemistry for cytokeratin 8].
Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):720-4. PubMed ID: 14974217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]